Skip to content

Primary care in Bath and North East Somerset serves a relatively small but highly varied population. The area combines the city of Bath, a large student population, affluent older communities, market towns, rural villages and areas of significant local inequality. The Care Quality Commission's 2025 assessment records a population of around 196,000.

The area's primary-care structure is organised through six Primary Care Networks: Bath Independents, Unity, Heart of Bath, Minerva, Keynsham and Three Valleys. These networks sit within NHS Bath and North East Somerset, Swindon and Wiltshire Integrated Care Board. Since 1 April 2026, BSW ICB has been working in a formal cluster with NHS Dorset and NHS Somerset. The three ICBs continue to exist as statutory bodies.

They now share a Cluster Board and executive structure, with the stated intention of moving toward a single strategic commissioning organisation from April 2027. For providers, the important point is that local B&NES pathways and PCNs still matter even as commissioning becomes more consolidated at cluster level. Community pharmacy is another major part of the local primary-care system.

The final B&NES Pharmaceutical Needs Assessment 2025–28 records 33 community pharmacies, one distance-selling pharmacy and five dispensing GP practices. The assessment concludes that there are no gaps in contracted pharmaceutical services. It also concludes that current provision is sufficient for the expected population during the life of the PNA.

The most important market distinction is therefore not whether B&NES has primary-care demand. It clearly does. The question is whether a new provider addresses a specific locality, patient group, pathway and access problem that existing GP, pharmacy and community services do not already meet.

B&NES primary care at a glance

Indicator, B&NES primary-care evidence
IndicatorB&NES primary-care evidence
PopulationAround 196,000 residents in CQC's 2025 assessment.
General practiceSix PCNs: Bath Independents, Unity, Heart of Bath, Minerva, Keynsham and Three Valleys.
Community pharmacy33 community pharmacies, one distance-selling pharmacy and five dispensing GP practices in the final 2025–28 PNA evidence; approximately 17 community pharmacies per 100,000 residents.
Local pharmacy distribution21 community pharmacies in Bath and Bathavon, five in Keynsham and Chew Valley and seven in Somer Valley.
Pharmaceutical needsNo gap in current contracted pharmaceutical services and no general future gap identified during the 2025–28 assessment period.
NHS commissioningBSW ICB in a formal cluster with Dorset and Somerset since April 2026; a single strategic commissioning organisation was planned for April 2027.

These figures come from different datasets and reference periods. They describe the structure and direction of the market rather than a single live operational snapshot.

Different patient markets across Bath, towns and rural areas

Bath, Keynsham, Somer Valley and rural communities do not form one homogeneous healthcare market. Bath combines students, employees, tourists and established residents, while many outlying communities have different age profiles, travel needs and available transport. Catchment analysis matters both for patient access and the viability of services requiring repeated in-person appointments.

Two universities and a substantial student population create demand for mental-health support, sexual and reproductive health, minor illness, travel-related services and neurodevelopmental assessment. However, these needs are already served in part by NHS practices, university-linked support and pharmacies. A clinic would need a more specific offer, such as additional specialist expertise, accessible appointment patterns or a clearly evidenced gap, rather than relying on student numbers alone.

Older residents and people with multiple long-term conditions may require medicines management, diagnostics, physiotherapy, chronic-disease monitoring and support to remain independent. In rural localities the problem may be travel and coordination rather than the total absence of services. Telephone and digital access can help, provided alternatives remain available for patients who cannot use them.

Affluence creates potential demand for privately funded healthcare but cannot substitute for evidence of willingness to pay. A service intending to support populations with greater deprivation or worse health outcomes may instead depend on NHS, public-health or employer commissioning.

Six PCNs and the local general-practice structure

The current BSW ICB listing identifies six B&NES PCNs.

Bath Independents

Includes Batheaston Medical Centre, Fairfield Park Health Centre and Widcombe Surgery.

Unity

Includes The Pulteney Practice and University Medical Centre. This gives Unity a particularly significant student and city-centre population.

Heart of Bath

Includes Oldfield Surgery and St James's Surgery.

Minerva

Includes Combe Down, Newbridge Surgery, Rush Hill Surgery and St Michael's Surgery.

Keynsham

Includes St Augustines Surgery, Temple House Surgery and Westview Surgery.

Three Valleys

Covers a much larger rural and semi-rural geography and includes practices across Chew Valley, Somer Valley and surrounding villages. This makes Three Valleys operationally different from the Bath city networks.

A new primary-care provider may need to work with one practice, one PCN, several PCNs, the B&NES place and the wider ICB or cluster. The route depends on the service. A county-wide marketing strategy is often less useful than a defined network pathway.

Neighbourhood health and multidisciplinary services

The primary-care model is increasingly organised around wider professional teams rather than GP appointments alone. PCNs can deploy clinical pharmacists, physiotherapists, paramedics, care coordinators, social prescribers and mental-health practitioners. This changes the competitive baseline for private and contracted services: an identified problem with GP waiting times may already be addressed through another member of a neighbourhood team.

The BSW 2026 commissioning plan places emphasis on care closer to home, prevention, integrated pathways and population health. A prospective provider should determine whether its service fills a genuine function that those networks cannot currently deliver, such as specialist diagnostics, a time-limited intervention or additional capacity under a defined contract. Good alignment with the direction of policy is helpful, but it is not procurement approval.

Referral pathways require attention to eligibility, clinical responsibility, information sharing and continuity. A service that depends on GP referrals should not assume practices have the capacity or incentive to refer patients without an agreed pathway. Providers should test feasibility with the relevant practices or PCNs, not infer referrals from the existence of a strategic neighbourhood-health priority.

ICB cluster governance and local commissioning

BSW ICB began operating in a formal cluster with Dorset and Somerset from 1 April 2026, with a shared board and executive arrangements. The stated ambition was a single strategic commissioning organisation from April 2027, but that proposed future structure should not be described as already in force. At the time of this report, statutory responsibility and current procurement arrangements still need to be checked against the organisations in place.

The practical effect for a new provider is a potentially changing decision-making landscape. A small local service may depend mainly on one GP practice or PCN, whereas an NHS-commissioned pathway may require place-level or ICB-level engagement. Larger strategic arrangements do not automatically eliminate local variation in Bath, Keynsham or the Somer Valley.

Before preparing a bid or clinical partnership, establish the commissioning organisation, decision maker, budget owner, procurement route and contract requirements currently applicable to the intended service. An informal expression of interest from a local clinician is not the same as a funded commissioning opportunity.

Community pharmacy provision across the three localities

The final B&NES Pharmaceutical Needs Assessment 2025–28 recorded 33 community pharmacies, compared with 36 in the previous assessment period. Of the 33, 21 were in Bath and Bathavon, five in Keynsham and Chew Valley, and seven in Somer Valley. This distribution follows settlement patterns, but pharmacy counts alone do not describe opening hours, travel times, clinical capacity or patient experience.

Community pharmacies in the final PNA, against the previous assessment
  1. Final PNA 2025–2833
  2. Previous assessment36
Community pharmacies by locality in the final PNA
  1. Bath and Bathavon

    21

  2. Somer Valley

    7

  3. Keynsham and Chew Valley

    5

33 community pharmacies in total. One distance-selling pharmacy and five dispensing GP practices sit outside this split.

Keynsham and Chew Valley also had one distance-selling pharmacy and two dispensing GP practices, while Somer Valley had three dispensing GP practices. Their existence affects access and the case for additional premises, especially outside the densest settlements. A would-be pharmacy operator should not compare only the number of high-street branches.

The statutory PNA nevertheless concluded that contracted pharmaceutical services were sufficient and identified no general current or future gap during the 2025–28 assessment period. This is a material constraint on any proposition premised on a publicly recognised need for another ordinary pharmacy. It does not rule out changes in circumstances, nor does it establish profitability for a new entrant.

Rural dispensing practices and pharmacy access

The five dispensing practices are:

Keynsham and Chew Valley

The listed practices include Chew Medical Practice and Harptree Surgery.

Somer Valley

The listed practices include Elm Hayes Surgery, St Mary's Surgery and Somer Valley Medical Group. These practices reduce the need for a community pharmacy in some rural locations.

PNA findings, closures and access constraints

The final Pharmaceutical Needs Assessment found no current gap in necessary contracted services and no general future gap during its 2025–28 period. The assessment considered population and projected housing change as well as the network of existing contractors. That conclusion should take precedence over a generic claim that rising population or a reduction in branch numbers requires a new pharmacy.

At the same time, closures, reduced hours, workforce pressures and medicine shortages can produce genuine inconvenience or discontinuity for patients. The distinction is between statutory sufficiency of pharmaceutical provision and the everyday quality or reliability of access. A private proposition may seek to improve the latter, but this does not amount to official evidence that an additional NHS pharmacy contract is needed.

The PNA warns that sustained or widespread temporary closures could create a future gap and that material changes may require reassessment. Prospective providers should check live opening hours and contractor lists, particularly in areas with limited alternatives, rather than using historic figures as a current inventory.

An investment case should explain precisely which patient journeys are difficult, how many people are affected, the legal and commissioning route, and why existing pharmacies, dispensing practices or Pharmacy First services cannot respond.

Pharmacy First and clinical community services

Community pharmacies now deliver more than dispensing. Services can include Pharmacy First, contraception, hypertension case finding, vaccination and New Medicine Service. A private primary-care provider therefore competes with pharmacy for some activity.

Patients can access NHS-funded care for defined common conditions through community pharmacy. A private minor-illness clinic needs a stronger value proposition. Potential differentiation could include broader diagnostics, continuity, longer consultations and more complex cases.

Long-term conditions, health inequality and prevention

B&NES has favourable average population-health indicators relative to many places, but this does not remove the workload of cardiovascular disease, diabetes, respiratory conditions, frailty, dementia and multimorbidity. Needs rise at different rates across age groups and localities. Providers should combine population-health evidence with current pathways and waiting-time data before specifying a service.

Overall affluence also obscures inequalities in particular communities. A high-need population may be least able to purchase private consultations or diagnostics. Therefore the existence of disease prevalence supports an assessment of need, not automatically an investable private market. Publicly commissioned prevention requires its own funding and evidence of health outcomes.

Long-term condition services often depend on follow-up, medicines management, interoperable records and communication with GP teams. A provider entering this space needs to establish who holds continuing clinical responsibility and whether the proposed intervention adds capacity, duplication or an unnecessary handoff.

Student health and other mental-health pathways

Bath's student population contributes distinctive demand around mental health, contraception, sexual health and neurodevelopmental support. The city also has NHS general practice and university wellbeing provision. A new service should identify where the existing pathway is constrained, whether students are willing or able to pay, and what follow-up arrangements apply during term time and university holidays.

Private ADHD or autism assessment, therapy and psychiatric services may address access concerns, but commercial viability and safe clinical practice depend on qualified clinicians, assessment standards and continuity arrangements. It would be misleading to infer the scale of unmet need from national publicity or student numbers alone.

Women's health is another potential niche, including menopause, fertility-related assessment and specialist diagnostics. Community pharmacy contraception services already meet some needs. Successful entry would involve defining the part of care not already provided promptly through GP, pharmacy or other NHS pathways, and demonstrating a market for that additional service.

Private healthcare, women's health and visitors

Bath and some surrounding communities have strong private-pay capacity. Potential services include private GP, diagnostics, health screening, physiotherapy, dermatology, women's health and specialist consultations. The main commercial constraint is competition.

Bath's tourism economy creates additional demand for urgent minor illness, travel-related healthcare, pharmacy and temporary prescriptions. Tourism can create volume. It can also be seasonal.

Occupational health and employer-funded services

The B&NES economy includes universities, tourism, hospitality, public services, professional services and manufacturing. Potential employer-funded services include occupational assessments, vaccinations, health surveillance and absence management. This can create a more stable revenue stream than consumer private care.

Digital provision, estate constraints and CQC scope

Remote consultation can help people in Chew Valley, Somer Valley and rural Bathavon. Potential uses include follow-up, triage, monitoring and specialist advice. A hybrid service should still provide non-digital access.

B&NES infrastructure planning identifies the need for improvements to GP estate as housing develops. Examples have included Oldfield Surgery, Combe Down, St Michael's, Twerton and Newbridge. This shows primary-care capacity is not only about workforce. Physical estate matters too.

The 2025 PNA assessed projected housing delivery. The statutory conclusion remained that existing pharmacy provision could meet expected demand. A new health service should therefore identify a different access problem.

A healthcare business does not need one standard registration. Relevant regulated activities can include Treatment of disease, disorder or injury, Diagnostic and screening procedures, Surgical procedures and remote medical advice or triage where applicable. The service model should determine scope.

What the B&NES primary-care evidence indicates

The evidence points to a varied primary-care market whose opportunities are more likely to arise from patient-group and pathway specificity than from an across-the-board absence of care. Existing PCNs, community pharmacies and dispensing practices form a substantial network. A credible proposal should show which patient need is not addressed adequately within that network and how the service would connect to it.

Service or market area, Evidence and decision implication
Service or market areaEvidence and decision implication
General practiceSix PCNs with varied city, town and rural catchments; assess existing extended and multidisciplinary access first.
Neighbourhood healthStrategic priority under BSW plans, but not evidence of an open procurement opportunity.
Community pharmacy33 community pharmacies, one distance-selling pharmacy and five dispensing GP practices in PNA evidence.
New NHS pharmacy supplyNo general gap identified in the final PNA 2025–28; test current changes and the statutory market-entry route.
Rural accessTravel and dispensing-practice coverage matter as well as pharmacy numbers.
Student healthConcentrated patient demand, but overlapping NHS and university services.
Older-person healthNeed for coordinated long-term-condition and frailty support; clinical pathways and payer must be defined.
Private diagnostics or clinicsPotential demand in some catchments; confirm competition, achievable fees and qualified staffing.
Employer-funded healthUniversities, tourism, public services and other employers create possible occupational-health routes; contracts must be independently secured.

The appropriate commercial response may be a contracted community service, a targeted private clinic, a hybrid access model or no new service at all. Those choices require different investment, governance and regulatory assumptions.

Questions before starting a B&NES primary-care service

A prospective provider should be able to answer:

  • Which PCN population is the service for?

  • Is the target market Bath, Keynsham, Somer Valley or rural B&NES?

  • What existing NHS pathway already meets the need?

  • How does community pharmacy affect the opportunity?

  • Do dispensing GP practices affect the rural market?

  • Is Pharmacy First already meeting part of the need?

  • Is the target population private-pay, NHS-funded or employer-funded?

  • Who will refer patients?

  • Can clinicians be recruited?

  • How will the service fit neighbourhood health?

  • Is tourism or student demand relevant?

  • Is primary-care estate part of the problem?

  • Which regulated activities apply?

  • What evidence demonstrates commercial viability?

Frequently asked questions

  • Which ICB covers Bath and North East Somerset?

    Read the answer

    NHS Bath and North East Somerset, Swindon and Wiltshire ICB remains the statutory ICB. Since April 2026 it has operated in a formal cluster with NHS Dorset and NHS Somerset.

  • How many PCNs are in B&NES?

    Read the answer

    Six: Bath Independents, Unity, Heart of Bath, Minerva, Keynsham and Three Valleys.

  • How many community pharmacies are there?

    Read the answer

    The final 2025 PNA records 33 community pharmacies.

  • Are there dispensing GP practices?

    Read the answer

    Yes. Five dispensing GP practices support eligible rural patients.

  • Does B&NES need more pharmacies?

    Read the answer

    The final 2025–28 PNA identifies no gap in current contracted services and no general future gap during the assessment period.

  • Why can pharmacy access still feel difficult?

    Read the answer

    Closures, temporary closures, reduced hours, staffing and medicine shortages can affect patient experience without creating a formal statutory gap.

  • Does a private clinic need CQC registration?

    Read the answer

    It depends on the regulated activities carried on. Registration scope should follow the actual clinical model.

About the data

This report uses the final B&NES Pharmaceutical Needs Assessment 2025–28, BSW ICB's published PCN arrangements and 2026 commissioning material, cluster-governance information, and local demographic and infrastructure evidence. These sources describe different reference periods; the reported pharmacy count and PCN structure should not be treated as an unchanged live operational register. The reported April 2027 change to strategic commissioning is a plan, not a confirmed completed reorganisation. Check current statutory bodies, contract ownership, pharmacy opening hours, practice membership and CQC-regulated activities before committing funds. This report analyses primary care rather than adult social-care placement capacity.

Could your healthcare service work in Bath and North East Somerset?

Explore local demand and existing healthcare services for your idea.